EuBiologics Co., Ltd. (206650.KQ) KOE
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In KRW
| Market Cap | 416.59B |
| Enterprise Value | 396.92B |
| P/E Ratio | 10.94 |
| PEG Ratio | -0.28 |
| Price/Sales Ratio | 2.6 |
| Price/Book Ratio | 1.75 |
| Enterprise/Revenue | 2.52 |
| Enterprise/EBITDA | 5.39 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.24 |
| Operating Margin | 0.35 |
| Return On Assets | 0.12 |
| Return On Equity | 0.16 |
| Revenue | 149.2B |
| Revenue/Share | 3,329.9 |
| Gross Profit | 85.35B |
| EBITDA | 70.66B |
| Net Income | 41.26B |
| Diluted EPS | 1,124.73 |
| Total Cash | 66.36B |
| Total Cash/Share | 1,806.61 |
| Total Debt | 3.66B |
| Total Debt/Equity | 0.02 |
| Current Ratio | 3.97 |
| Book Value Per Share | 4,941.86 |
| 52-Week Change | -30.66 |
| 52-Week High | 17,700 |
| 52-Week Low | 6,950 |
| Moving Average 50 Days | 8,562.8 |
| Moving Average 200 Days | 11,600.4 |
| Average Volume | 197,820 |
| Shares Outstanding | 36.72M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 517:500 |
| Last Split Date | November 12, 2020 |